DIABETIC MACULAR EDEMA

This study tested whether a drug called PRO-169 works as well as the standard treatment, Lucentis (ranibizumab), for diabetic macular edema—a common cause of vision loss in people with diabetes. Over 500 adults received monthly eye injections of one of the two drugs for a year, w…

This study aimed to test a new way to treat diabetic macular edema, a swelling in the eye that can cause vision loss. It compared two doses of a long-acting steroid medicine delivered by a special illuminated catheter against a standard steroid implant. The trial was stopped earl…

This study tested a new eye injection called AG-73305 in people with diabetic macular edema, a condition where diabetes causes fluid buildup in the eye that can damage vision. Researchers gave 25 participants different doses of the injection to check if it was safe and if it help…

This study tested a new oral medication called RZ402 for diabetic macular edema (DME), a swelling in the back of the eye that can cause vision loss in people with diabetes. The goal was to see if taking the pill daily for 12 weeks was safe and could reduce the swelling better tha…

This study tested whether adding a new drug called vamikibart to a standard eye injection (ranibizumab) works better for diabetic macular edema (DME) than the standard injection alone. DME is a swelling in the back of the eye that can cause vision loss in people with diabetes. Th…

This study aimed to collect more safety information about an approved eye injection (aflibercept) for diabetic macular edema (DME) specifically in Indian patients. DME is a diabetes complication where fluid leaks into the retina, causing vision loss. Over 52 weeks, researchers mo…

This study tested a new medication called vamikibart, given as an injection into the eye, for people with diabetic macular edema (DME), a condition that causes vision loss. It compared the new injection to an existing treatment to see if it was better at improving or preserving e…

This study compared two types of eye injections given one week before cataract surgery to people with diabetic macular edema (swelling in the back of the eye). The goal was to see which injection—a steroid (Ozurdex) or an anti-VEGF drug (like Avastin or Eylea)—was better at preve…

This study followed patients who had already completed earlier trials of faricimab, a medication injected into the eye to treat diabetic macular edema (swelling in the back of the eye). Researchers monitored 1,479 patients for long-term side effects, particularly looking for any …

This study aimed to understand how much of a high-dose eye medication gets into the bloodstream when injected into both eyes. It involved 51 adults with diabetic macular edema or 'wet' age-related macular degeneration. Researchers measured the highest drug concentration in partic…

This study aimed to measure the thickness of specific eye tissues in patients with two common vision conditions (neovascular age-related macular degeneration and diabetic macular edema) and compare them to healthy volunteers. Researchers used a special imaging scan to take these …

This study aimed to find out if specific patterns seen on standard eye scans could predict how well a patient with diabetic macular edema (a common cause of vision loss in diabetes) would respond to treatment. Researchers observed 32 patients, analyzing their routine eye scan ima…